CITrials is excited to announce merger with CenExel

CITrials is excited to announce that we are now part of CenExel Clinical Research, Inc., (“CenExel”). This merger with CenExel allows CITrials to strengthen and increase the clinical studies that we offer in psychiatric and neurological research and new studies. To our patients, nothing changes except soon, there will be more clinical studies to participate […]

Working Together to Continue Clinical Trials

Our volunteers are scared that we will shut our doors, forget their needs and they will go without medication, We can’t do that to them now! CITrials rates volunteers using our “In-Office-Virtual-Ratings” please see pictures above! CITrials can continue to guarantee the same raters and consistency using our “In-Office-Virtual-Ratings” while responsibly using “In Office Rater Distancing” CITrials has contingency measures implemented to […]

Did you know that bacteria associated with gum disease may cause Alzheimer’s?

Even if you have no symptoms of gum disease, you may still be at risk. Consider joining a new clinical trial evaluating whether an investigational drug is safe and can halt the progression of Alzheimer’s disease by reducing the damage caused by oral bacteria that travel to the brain. Watch the video below to learn […]

CITrials Taking Extra Steps Against COVID-19

Here at CITrials, the safety and well-being of our participants and employees is always our primary concern. The evolving situation with COVID-19 (Coronavirus) has prompted us to take extra steps and precautions to ensure the health of everyone who visits our clinics. Being part of the medical community, we are constantly receiving the latest updates […]

Congress of the Schizophrenia International Research Society

We welcome you to attend the Annual Congress of the Schizophrenia International Research Society in Florence, Italy 4-8 April 2020. CEO, Debra Hoffmeyer, will be attending. Please reach out to schedule time to talk about CITrials and our clinical trial experience. Some of the great topics covered at the meeting will be Current Considerations in […]

CITrials COVID-19 Update

CITrials continually assess our local, state, and federal health guidelines.  Our team has a contingency and continuity policy for virus control that will not impact daily activities, including but not limited to volunteer visits, on-site services, study medications, supplies, and labs.   CITrials teams are doing our part to assist our fellow medical professionals during this current health […]

CITrials to Attend ‘The 2020 European Site Solutions Summit’ in March

CiTrials will be flying to Portugal this March to participate in the European Site Solutions Summit, an event organized by the renowned Society for Clinical Research Sites to further growth and networking in the field of clinical trials. This program, which is based on objectives and ideas from each attending country, will offer a gathering […]

New Medication Approved For Alzheimer’s Disease

Belsroma, a new drug for Alzheimer’s induced insomnia, has been approved by the FDA thanks to the research done by CITrials. This new medication can help patients that suffer from mild-to-moderate Alzheimers. With the help of Belsroma, said patients can experience less disruption during sleep. This 4-week study had 285 participants, with significant improvement in […]

CITrials to Attend ‘The 2020 European Site Solutions Summit’ in March

CiTrials will be flying to Portugal this March to participate in the European Site Solutions Summit, an event organized by the renowned Society for Clinical Research Sites to further growth and networking in the field of clinical trials. This program, which is based on objectives and ideas from each attending country, will offer a gathering […]

Is Schizophrenia affecting your child’s social development?

CITrials is currently enrolling a clinical research trial on Adolescent Schizophrenia ages 13 to 17 years old. Symptoms may include hallucinations, change in behavior, and delusions. If you feel your child is need of treatment please give us a call at 866-478-8391.